InvestorsHub Logo
Followers 99
Posts 4467
Boards Moderated 0
Alias Born 09/02/2009

Re: None

Tuesday, 09/16/2014 11:26:11 AM

Tuesday, September 16, 2014 11:26:11 AM

Post# of 379
NEWS: FDA Approves the Use of a Needle-Free Injection Device to Administer the Influenza Vaccine

http://www.otcmarkets.com/news/otc-market-headline?id=16449607

PHOENIX and VANCOUVER, British Columbia, Sep 16, 2014 (GLOBE NEWSWIRE via COMTEX) -- Eternity Healthcare Inc. (OTC:ETAH), a medical device and diagnostic company with advanced technologies using the Needle-Free Injection system announced today that its competitor company, PharmaJet(R) Inc., has received FDA clearance to use a Needle-Free Injection device to administer the influenza vaccine to the public.
The following is from a release dated August 19, 2014:

"PharmaJet(R) Inc., the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL Inc., the maker of AFLURIA(R) (Influenza Vaccine) today announced the U.S. Food and Drug Administration (FDA) has approved the PharmaJet Stratis(R) 0.5mL Needle-Free Jet Injector for delivery of AFLURIA in individuals aged 18 to 64 years. This is the first needle-free delivery system approved by the FDA for the administration of an inactivated influenza vaccine."

Dr. Salari, C.E.O. of Eternity Healthcare Inc. said, "With this new FDA approval, it opens the door for a large number of injectable drugs, from insulin to different types of vaccines and vitamins, to be injected without the use of needles." He went on to state: "Using a Needle-Free Injection Device to administer vaccines will not only be less painful, but will eliminate accidental poking and reducing the risk of transmitting diseases. This is truly important in developing countries." Dr. Salari further suggests that Eternity Healthcare Inc. is performing experimental work with some other types of vaccines using the Comfort-in(TM) Needle-Free Injection System.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.